Literature DB >> 6975219

Purification and characterization of C4-binding protein from human serum.

M B Villiers, A Reboul, N M Thielens, M G Colomb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6975219     DOI： 10.1016/0014-5793(81)80425-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  7 in total

Review 1.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

2.  Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchrotron X-ray scattering and hydrodynamic analysis.

Authors:  S J Perkins; L P Chung; K B Reid
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

3.  Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex.

Authors:  B Dahlbäck; B Hildebrand
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

4.  Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S.

Authors:  B Dahlbäck
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

5.  Soluble C3 proconvertase and convertase of the classical pathway of human complement. Conditions of stabilization in vitro.

Authors:  M B Villiers; N M Thielens; M G Colomb
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

6.  C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition.

Authors:  Helena Païdassi; Pascale Tacnet-Delorme; Virginie Garlatti; Claudine Darnault; Berhane Ghebrehiwet; Christine Gaboriaud; Gérard J Arlaud; Philippe Frachet
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

7.  Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathway.

Authors:  L Bergamaschini; A Miedico; M Cicardi; R Coppola; E N Faioni; A Agostoni
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.